LogoPressRelease.jpg
Fluidigm Announces Sale of $30 Million of Common Stock in At-The-Market Equity Offering
August 10, 2017 19:20 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the sale of 9,090,909 shares of its common stock for aggregate gross proceeds of...
LogoPressRelease.jpg
Fluidigm Announces Second Quarter Financial Results and Operational Progress
August 03, 2017 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced financial results for the second quarter ended June 30, 2017. Total revenue for the...
LogoPressRelease.jpg
Fluidigm 和 Ascendas Genomics 宣布建立战略合作关系在中国开发微流控分子诊断
August 02, 2017 22:51 ET | Fluidigm Corporation
加州南旧金山与中国中山市, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation(NASDAQ:FLDM)与 Ascendas Genomics 今日宣布建立战略合作,在中国开发分子诊断技术。 根据合作条款,Ascendas Genomics 将使用 Fluidigm® Biomark™ HD 和 Juno™...
LogoPressRelease.jpg
Fluidigm Corporation Announces Termination of Tax Benefit Preservation Plan
August 02, 2017 06:00 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) announced today that its tax benefit preservation plan had expired pursuant to its terms,...
LogoPressRelease.jpg
Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China
July 27, 2017 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif. and ZHONGSHAN, China, July 27, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Ascendas Genomics today announced a strategic partnership to develop...
LogoPressRelease.jpg
Fluidigm to Report Q2 2017 Financial Results and Host Conference Call
July 20, 2017 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 20, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will report second quarter 2017 financial results on Thursday, August 3,...
LogoPressRelease.jpg
Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research
July 18, 2017 09:00 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 18, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the launch of the Advanta™ Immuno-Oncology Gene Expression Assay, an optimized qPCR...
LogoPressRelease.jpg
European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research
May 04, 2017 16:10 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that leading research institutions in the UK have partnered to acquire and implement...
LogoPressRelease.jpg
Fluidigm Announces First Quarter Financial Results
May 04, 2017 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the first quarter ended March 31, 2017. Total revenue...
LogoPressRelease.jpg
Fluidigm to Report Q1 2017 Financial Results and Host Conference Call
April 20, 2017 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., April 20, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced it will report first quarter 2017 financial results on Thursday, May 4, 2017, after...